Related Experiment Videos
Nuclear factor kappaB inhibitors induce adhesion-dependent colon cancer apoptosis: implications for metastasis
Courtney L Scaife1, Jinqiu Kuang, Jason C Wills
1Department of Surgery, Salt Lake City Veterans Administration Medical Center, and University of Utah, Salt Lake City, Utah 84132, USA.
Abstract:
The transcription factor nuclear factor kappaB (NFkappaB) is constitutively active in many types of cancercells and regulates the expression of several antiapoptotic genes. Previous studies demonstrated a role for the inhibition of NFkappaB in cancer therapyusing a transgenic approach in mice. We found that NFkappaB was transiently activated much greater than background constitutive levels during colon cancer cell readhesion, which rendered the readhering colon cancer cells exquisitely susceptible to apoptosis in the presence of soluble NFkappaB inhibitors. These compounds greatly reduced colon cancer cell implantation in an in vivo seeding model of metastasis. The ability of soluble NFkappaB inhibitors to significantly induce apoptosis of readherent colon cancer cells makes them prospective candidates for preventing colon cancer metastasis.
Insights
Soluble NF-kappaB inhibitors induce apoptosis in colon cancer cells during readhesion, significantly reducing metastasis. This finding highlights their potential for preventing colon cancer spread.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Nuclear factor kappaB (NF-kappaB) is constitutively active in many cancers, regulating antiapoptotic genes.
- Previous research indicated NF-kappaB inhibition's role in cancer therapy using transgenic mice.
Purpose of the Study:
- To investigate the role of NF-kappaB activation during colon cancer cell readhesion.
- To evaluate the efficacy of soluble NF-kappaB inhibitors in targeting colon cancer metastasis.
Main Methods:
- Monitoring NF-kappaB activation levels during colon cancer cell readhesion.
- Assessing apoptosis induction in readherent colon cancer cells with soluble NF-kappaB inhibitors.
- Evaluating the impact of these inhibitors on colon cancer cell implantation in an in vivo metastasis model.
Main Results:
- NF-kappaB was transiently activated at higher levels than constitutive activity during colon cancer cell readhesion.
- Readherent colon cancer cells showed increased susceptibility to apoptosis when treated with soluble NF-kappaB inhibitors.
- These inhibitors significantly reduced colon cancer cell implantation in a metastasis model.
Conclusions:
- Transient NF-kappaB activation during colon cancer cell readhesion creates a therapeutic window.
- Soluble NF-kappaB inhibitors effectively induce apoptosis in readherent colon cancer cells.
- NF-kappaB inhibitors show promise as a strategy for preventing colon cancer metastasis.